Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial


Hamuryudan V. , Mat C., Saip S. , Ozyazgan Y. , Siva A. , Yurdakul S. , ...Daha Fazla

ANNALS OF INTERNAL MEDICINE, cilt.128, ss.443-451, 1998 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Background: Recurrent oral and genital ulcers are the most frequent problem in the management of the Behcet syndrome. Uncontrolled experience suggests that thalidomide may help prevent recurrences of these ulcers.